Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity.


Ugurluer G. , Atalar B. , Zoto M., Gungor G. , Aydin G., Sengoz M., ...Daha Fazla

The British journal of radiology, cilt.94, ss.20200696, 2021 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 94
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1259/bjr.20200696
  • Dergi Adı: The British journal of radiology
  • Sayfa Sayıları: ss.20200696

Özet

Objective: Using moderate or ultra-hypofractionation, which is also known as stereotactic body radiotherapy (SBRT) for treatment of localized prostate cancer patients has been increased. We present our preliminary results on the clinical utilization of MRI-guided adaptive radiotherapy (MRgRT) for prostate cancer patients with the workflow, dosimetric parameters, toxicities and prostate-specific antigen (PSA) response.